Evidence map›Paper›PMID 41973256›Full record

ArticleJournal of molecular modeling2026

HopWD-DTA: a novel framework for drug-target affinity prediction fusing multi-hop neighborhoods and deep features.

Xingyu Liu, Maoyuan Zhou, Xiaorui Huang, Jirui Zhang, Jiaxing Li, Zhenghui Wang, Lixin Lei, Kaitai Han, Nasrollah Moghadam, Hossein Ganjidoust and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xingyu LiuAcademy of Artificial Intelligence, Beijing Institute of Petrochemical Technology, Beijing, 102617, China.
Maoyuan ZhouAcademy of Artificial Intelligence, Beijing Institute of Petrochemical Technology, Beijing, 102617, China.
Xiaorui HuangAcademy of Artificial Intelligence, Beijing Institute of Petrochemical Technology, Beijing, 102617, China.
Jirui ZhangAcademy of Artificial Intelligence, Beijing Institute of Petrochemical Technology, Beijing, 102617, China.
Jiaxing LiAcademy of Artificial Intelligence, Beijing Institute of Petrochemical Technology, Beijing, 102617, China.
Zhenghui WangAcademy of Artificial Intelligence, Beijing Institute of Petrochemical Technology, Beijing, 102617, China.
Lixin LeiAcademy of Artificial Intelligence, Beijing Institute of Petrochemical Technology, Beijing, 102617, China.
Kaitai HanAcademy of Artificial Intelligence, Beijing Institute of Petrochemical Technology, Beijing, 102617, China.
Nasrollah MoghadamDepartment of Computer Engineering, Tarbiat Modares University, Tehran, Iran.
Hossein GanjidoustEnvironmental Engineering Division Civil & Environmental Engineering Faculty, Tarbiat Modares University, Tehran, Iran.
Qianjin GuoAcademy of Artificial Intelligence, Beijing Institute of Petrochemical Technology, Beijing, 102617, China. guoqj@iccas.ac.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextAccurate prediction of drug-target affinity (DTA) is crucial for accelerating drug discovery, but it remains a significant challenge. While deep learning methods have shown promise, many existing models struggle with representing long-range protein relationships within protein-protein interaction (PPI) networks, often suffering from performance degradation as graph neural network layers deepen. To overcome this limitation, we developed HopWD-DTA, a novel framework designed to effectively capture both local and global protein features. The core innovation lies in integrating multi-hop neighborhood information from PPI networks with deep structural features of proteins and drugs. Comprehensive evaluations on the Davis, KIBA, and Human benchmark datasets demonstrate that HopWD-DTA achieves state-of-the-art performance, significantly improving DTA prediction accuracy over existing cutting-edge solutions.

methodsThe HopWD-DTA framework consists of separate branches for protein and drug feature extraction. For proteins, structural features from residue contact maps are first encoded using a Graph Convolutional Network (GCN). These features, along with InterPro annotations, are then embedded into a PPI network. We introduce a multi-hop neighborhood serialization technique, which generates a sequence of feature matrices representing different neighborhood scopes. This sequence is processed by a Variational Autoencoder (VAE) to learn a robust protein representation. For drugs, molecules are represented as graphs from SMILES strings and encoded via a GCN, followed by a novel Wide-and-Deep Path (WDPATH) module to capture both macroscopic and microscopic features. The final protein and drug features are concatenated and fed into a multilayer perceptron for affinity prediction. The model was implemented using PyTorch and RDKit.

Indexed as

Deep LearningDrug DiscoveryProteinsGraph Neural NetworksHumansNeural Networks, ComputerProtein Interaction MapsProteinsDrug-target affinityGraph neural networkMulti-hop neighborhood serializationPPI networksVariational autoencoder

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.